Provexis plc (PXS) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.467x

Based on the latest financial reports, Provexis plc (PXS) has a cash flow conversion efficiency ratio of -0.467x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-357.00K ≈ $-43.44 USD) by net assets (GBX763.82K ≈ $92.93 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Provexis plc - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Provexis plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Provexis plc (PXS) financial obligations for a breakdown of total debt and financial obligations.

Provexis plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Provexis plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TTA Holdings Ltd AU:TTA	-0.073x
TUT Fitness Group Inc V:GYM	-2.978x
Crown LNG Holdings Limited Ordinary Shares NASDAQ:CGBS	-0.192x
Goldplat PLC LSE:GDP	0.009x
Tongaat JSE:TON	1.602x
Sino-German United AG F:SGU	N/A
Cirata plc LSE:CRTA	-0.638x
iomart Group plc LSE:IOM	0.079x

Annual Cash Flow Conversion Efficiency for Provexis plc (2004–2025)

The table below shows the annual cash flow conversion efficiency of Provexis plc from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Provexis plc (PXS) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX763.82K ≈ $92.93	GBX-340.83K ≈ $-41.47	-0.446x	+55.59%
2024-03-31	GBX190.59K ≈ $23.19	GBX-191.50K ≈ $-23.30	-1.005x	-27.11%
2023-03-31	GBX657.65K ≈ $80.02	GBX-519.85K ≈ $-63.25	-0.790x	-258.73%
2022-03-31	GBX969.08K ≈ $117.91	GBX-213.54K ≈ $-25.98	-0.220x	+3.97%
2021-03-31	GBX1.14 Million ≈ $138.97	GBX-262.07K ≈ $-31.89	-0.229x	+78.15%
2020-03-31	GBX318.68K ≈ $38.77	GBX-334.64K ≈ $-40.72	-1.050x	+7.33%
2019-03-31	GBX338.89K ≈ $41.23	GBX-384.01K ≈ $-46.72	-1.133x	-2.77%
2018-03-31	GBX329.26K ≈ $40.06	GBX-363.05K ≈ $-44.17	-1.103x	+93.62%
2017-03-31	GBX24.89K ≈ $3.03	GBX-430.30K ≈ $-52.36	-17.291x	-574.63%
2016-03-31	GBX142.84K ≈ $17.38	GBX-366.10K ≈ $-44.54	-2.563x	-55.70%
2015-03-31	GBX245.90K ≈ $29.92	GBX-404.78K ≈ $-49.25	-1.646x	-53.62%
2014-03-31	GBX535.08K ≈ $65.10	GBX-573.34K ≈ $-69.76	-1.072x	-491.02%
2013-03-31	GBX7.91 Million ≈ $961.92	GBX-1.43 Million ≈ $-174.40	-0.181x	+5.42%
2012-03-31	GBX11.30 Million ≈ $1.37K	GBX-2.17 Million ≈ $-263.54	-0.192x	-7.20%
2011-03-31	GBX11.48 Million ≈ $1.40K	GBX-2.05 Million ≈ $-249.79	-0.179x	-31.87%
2010-03-31	GBX11.06 Million ≈ $1.35K	GBX-1.50 Million ≈ $-182.51	-0.136x	+44.43%
2009-03-31	GBX5.53 Million ≈ $673.08	GBX-1.35 Million ≈ $-164.26	-0.244x	-24.48%
2008-03-31	GBX7.58 Million ≈ $922.88	GBX-1.49 Million ≈ $-180.92	-0.196x	+40.54%
2007-03-31	GBX6.61 Million ≈ $804.12	GBX-2.18 Million ≈ $-265.12	-0.330x	-6.14%
2006-03-31	GBX8.85 Million ≈ $1.08K	GBX-2.75 Million ≈ $-334.47	-0.311x	+87.48%
2005-03-31	GBX510.00K ≈ $62.05	GBX-1.26 Million ≈ $-153.91	-2.480x	+64.89%
2004-03-31	GBX108.00K ≈ $13.14	GBX-763.00K ≈ $-92.84	-7.065x	--

About Provexis plc

LSE:PXS UK Drug Manufacturers - Specialty & Generic

Market Cap

$291.14K

GBX2.39 Billion GBX

Market Cap Rank

#30726 Global

#978 in UK

Share Price

GBX1.02

Change (1 day)

+0.00%

52-Week Range

GBX0.50 - GBX1.51

All Time High

GBX1.51